🇺🇸 Cannabis Sativa Oil in United States

168 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 168

Most-reported reactions

1. Arthralgia — 25 reports (14.88%)
2. Drug Ineffective — 24 reports (14.29%)
3. Pain — 23 reports (13.69%)
4. Fatigue — 19 reports (11.31%)
5. Nausea — 15 reports (8.93%)
6. Dizziness — 13 reports (7.74%)
7. Joint Swelling — 13 reports (7.74%)
8. Psoriatic Arthropathy — 13 reports (7.74%)
9. Headache — 12 reports (7.14%)
10. Off Label Use — 11 reports (6.55%)

Source database →

Frequently asked questions

Is Cannabis Sativa Oil approved in United States?

Cannabis Sativa Oil does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Cannabis Sativa Oil in United States?

Fondation pour l'accueil et l'hébérement des personnes âgées is the originator. The local marketing authorisation holder may differ — check the official source linked above.